Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ADVANCED PAIN MANAGEMENT CENTER OF OKLAHOMA, LLC

NPI: 1437657590 · TULSA, OK 74135 · Pain Medicine (Anesthesiology) Physician · NPI assigned 01/24/2018

$2.23M
Total Medicaid Paid
32,497
Total Claims
31,646
Beneficiaries
23
Codes Billed
2021-10
First Month
2024-11
Last Month

Provider Details

Authorized OfficialSALGUERO, ALESHA (CEO)
NPI Enumeration Date01/24/2018

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 2,407 $162K
2022 10,173 $797K
2023 11,861 $859K
2024 8,056 $411K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 10,640 10,144 $813K
64483 1,792 1,788 $293K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 3,700 3,511 $184K
64635 474 474 $169K
64636 421 419 $162K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2,625 2,562 $142K
62321 575 574 $95K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 839 839 $95K
99152 2,572 2,559 $82K
64484 882 879 $60K
64493 210 204 $37K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 291 289 $29K
64494 202 196 $19K
20610 332 298 $12K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2,140 2,132 $10K
77002 141 133 $9K
27096 51 51 $6K
64495 39 37 $5K
62323 29 29 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,763 2,753 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg 1,223 1,220 $494.30
J3010 Injection, fentanyl citrate, 0.1 mg 374 374 $238.91
J2704 Injection, propofol, 10 mg 182 181 $5.40